SCHEMBL28039788

SCHEMBL28039788

COC(=O)[C@H](C)N(CCc1ccccc1)CC1CCN1

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 7/20 0.41
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
SLC6A3 Q01959 4/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 1/20 0.39
DHFR P00374 1/20 0.39
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16403329 0.88 GHSR (0.47) GHSRALDH1A1SLC6A3SLC6A2SLC6A4
SCHEMBL17685972 0.88 GHSR (0.47) GHSRALDH1A1SLC6A3SLC6A2SLC6A4
Hydrochloric Acid SCHEMBL17686009 0.87 GHSR (0.47) GHSRALDH1A1SLC6A3SLC6A2SLC6A4
Hydrochloric Acid SCHEMBL17686008 0.87 GHSR (0.47) GHSRALDH1A1SLC6A3SLC6A2SLC6A4
SCHEMBL16401060 0.75 GHSR (0.48) GHSRSLC6A2SLC6A4
SCHEMBL70476 0.73 EPOR (0.48)
SCHEMBL5655937 0.71 KMT2A (0.56) ALDH1A1MAPTLMNATDP1
SCHEMBL12492396 0.71 KMT2A (0.56) ALDH1A1MAPTLMNATDP1
SCHEMBL5655931 0.71 KMT2A (0.56) ALDH1A1MAPTLMNATDP1
SCHEMBL17691239 0.70 GHSR (0.41) GHSRALDH1A1SLC6A3SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105408331-A Triazolopyridines as thrombin inhibitors for the treatment of thromboembolic disorders Bayer Pharma AG 2016-03-16 CN disclosed